Discover 1,123 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,123
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
for
Fabry Disease
Location: Fairfax VA, Atlanta GA, Grand Rapids MI, Birmingham AL,
Sponsor: Chiesi Farmaceutici S.p.A.
Sex: All
Age: 18+
Code: NCT06663358
Recruiting
Investigating Inhibitory Control Networks in Parkinson's Disease
for
Parkinson Disease
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT04735458
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Boston MA, New Haven CT, New York NY, Paramus NJ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase 3, Recruiting
HCRN Core Data Project: Characterizing Patient Populations in the Hydrocephalus Clinical Research Network (HCRN)
Investigating Dynamic Interactions in Distributed Cognitive Control Networks
for
Cognitive Impairment, Dementia, ADD, Depression
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT05927974
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: Halifax, Moncton, Rimouski, Farmington CT, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase 3, Recruiting
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants
for
Ductus Arteriosus, Patent
Location: Boston MA, Hollywood FL, Orlando FL, Columbus OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 0
Code: NCT05547165
Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant